Market Growth Driven by Rising Demand for Biopharmaceuticals, Precision Medicine Development, Biotechnology R&D Investments, Single-Use Technologies, and AI Integration in Manufacturing Processes ...

Market Growth Driven by Rapid Disposable Technology Adoption, Expanding Biopharmaceutical Sector, and Government Support for ...

Thermo Fisher did not immediately respond to a Reuters' request for comment. In February, the company acquired Solventum's purification and filtration business for about $4.1 billion in cash.

Thermo Fisher did not immediately respond to a Reuters' request for comment. In February, the company acquired Solventum's purification and filtration business for about $4.1 billion in cash.

Recent discussions on X regarding Thermo Fisher Scientific (TMO) have centered around the company's reported plan to sell parts of its diagnostics division for approximately $4 billion. Many users ...

Review quarterly and annual revenue, net income, and cash flow for Thermo Fisher Scientific Inc (TMO:XNYS) stock through the last fiscal year.

Learn about the executive team and board of directors at Thermo Fisher Scientific Inc (TMO:XNYS) and review their bios and compensation over the latest fiscal years.

Medical bioreactor market was valued at US$ 4.31 billion in 2024 and is projected to hit the market valuation of US$ 7.04 billion by 2033 at a CAGR of 5.80% during the forecast period 2025–2033.

Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

By combining a reusable imager with a single-use blade, the Slimline C-MAC S scope reduces environmental impact by minimizing electronic waste. 1 The innovative blade design cuts material use by ...